ORIGINAL_ARTICLE
Comparison of the effectiveness of different oral glucose lowering drugs in fasting patients with type II diabetes
Introduction: Type 2 diabetes is the most common metabolic diseases in developed and developing countries with no effective treatment options. This study purpose was to compare different regimens of oral anti-diabetic therapy effects on the type 2 diabetic patients while fasting during Ramadan. Methods: In the double-blind controlled trial 90 patients with type 2 diabetes were divided randomly into three groups: 30 patients continued the previous dose of sulfonylurea (Group 1), 30 participants received a dose which was 25% lower than the previous sulfonylurea dose (group 2), and in the last 30 patients, repaglinide was replaced sulfonylurea (Group 3). Glucose, glycosylated hemoglobin (HbA1C), fructosamine, total cholesterol, low-density lipoprotein (LDL), high density lipoprotein (HDL), and triglycerides levels were measured in all participants before and after Ramadan. The weight and BMI were also controlled. Results: In all intervention groups a significant decreasing was seen in the body weight, BMI, fructoseamine, total cholesterol, and LDL; and also, a significant increasing was seen in HDL. The hypoglycemia incidence was significantly lower in Group 3 than Group 1. The results in fructosamine reduction and HDL cholesterol increasing were significantly better in Group 3 compared to Group 2 (P<0.05). Significant changes were not seen in total cholesterol, LDL, triglyceride, FBS, and HbA1C levels among the three treatment groups during Ramadan. Conclusion: The repaglinide consumption in comparing with sulfonylurea in patients with diabetes during Ramadan can cause fewer hypoglycemia, and better glycemic, and lipid control.
https://www.ijbmph.com/article_61057_e131a1a08e565475e7922137717c538a.pdf
2018-04-27
59
66
10.22631/ijbmph.2018.118140.1020
Hypoglycemia
Metformin
Repaglinide
Sulfonylurea
Type II diabetes
Mernoosh
Zakerkish
mehr.zaker@yahoo.com
1
Department of Endocrinology, Health Research Institution, Diabetes Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
LEAD_AUTHOR
Hajiyeh Bibi
Shahbaziyan
hajiyehbibi.shahbaziyan@yahoo.com
2
Department of Endocrinology, Diabetes Research Center,Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
AUTHOR
Majid
Karandish
majid.karandish@gmail.com
3
Department of Nutrition, Faculty of Paramedicine, Diabetes Research Center,Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
AUTHOR
Homira
Rashidi
homira.rashidi@gmail.com
4
Department of Endocrinology, Diabetes Research Center,Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
AUTHOR
Seyed Peyman
Payami
peyman.payami@gmail.com
5
Department of Endocrinology, Diabetes Research Center,Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
AUTHOR
1. Rathmann W, Giani G. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27 (10): 2568–9.doi: 10.2337/diacare.27.10.2568
1
2. Latifi SM, Karandish M, Shahbazian H, Hardani Pasand L. Incidence of Prediabetes and Type 2 Diabetes among People Aged over 20 Years in Ahvaz: A 5-Year Perspective Study (2009-2014). J Diabetes Res 2016; 2016: 4908647. doi: org/10.1155/2016/4908647.
2
3. Golozar A, Khalili D, Etemadi A, Poustchi H, Azeltabar A, Hosseini F, et al. White rice intake and incidence of type-2 diabetes: analysis of two prospective cohort studies from Iran. BMC Public Health 2017; 17(1): 133. doi: 10.1186/s12889-016-3999-4
3
4. Nasli-Esfahani E, Farzadfar F, Kouhnavard M, Ghodssi-Ghassemabadi R, Khajavi A, Peimaniet M, et al. Iran diabetes research roadmap (IDRR) study: a preliminary study on diabetes research in the world and Iran. J Diabetes Metab Disord 2017; 16 (1): 9. doi: 10.1186/s40200-017-0291-9
4
5. Hosseini SA, Alipour M, Zakerkish M, Haghighizade M H. Effects of Standardized Extract of Ginseng (G115) on Biomarkers of Systemic Low-Grade Inflammation in Patients with Type 6 diabetes: A Double-blind Clinical Trial. Iranian J Endocrinol Metabol 2014; 16(3):175-82.
5
6. Hosseini SA, Alipour M, Zare Javid A, Ashtary Larky D, Shariatifar R. Impact of Short – Term Intake of Cinnamon on Serum Glucose and Lipid Profile in Patients with Type 2 Diabetes Mellitus. J Appl Environ Biol Sci 2014; 4(2):295- 8.
6
7. Ashtary-Larky D, Ghanavati M, Lamuchi-Deli N, Payami SA, Alavi-Rad S, Boustaninejad M, et al. Rapid Weight Loss vs. Slow Weight Loss: Which is More Effective on Body Composition and Metabolic Risk Factors? Int J Endocrinol Metab 2017; 15(3):e13249. doi: 10.5812/ijem.13249
7
8. SA Hosseini, A Ahangarpour, M Ghanavati, M Aria, M Alipour. Review effects of ginseng on improving glycemic status and other related parameters with Type 2 diabetes. J Clin Exc 2015; 4 (Special Issue), 90-107.
8
9. Malik U, Mahmood N, Khan KA, Hameed M, Randhawa FA, Salman S, et al. Glycaemic Control Of Type 2 Diabetic Patients During Ramazan Fasting. J Ayub Med Coll Abbottabad 2017; 29(1):102-6.
9
10. Salti I, Bénard E, Detournay B, Bianchi-Biscay M, Le Brigand C, Voinet CB, et al. A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study. Diabetes care 2004; 27:2306-2311.
10
11. Azizi F. Islamic Fasting and health. Ann Nutr Metabol 2010; 56 (4): 273-82. doi: 10.1159/000295848
11
12. Glimperide in Ramadan (GLIRA) Study Group. The efficacy and Safety of Glimepiride in The management of type 2 diabetes in Muslim Patients during Ramadan. Diabetes care 2005; 28 (2): 421-2. doi: 10.2337/diacare.28.2.421
12
13. AnwarA, Azmi KN, Hamidon BB, khalid BA. An open label comparative study of glimepiride versus repaglinide in type 2 diabetes mellitus muslim subjects during the month of Ramadan. Med J Malaysia 2006; 61 (1):28-35.
13
14. Zargar AH, SirajM, Jawa AA,Hasan M, Mahtab H. Maintenance of glycaemic control with the evening administration of a long acting sulphonylurea in male type 2 diabetic patients undertaking the Ramadan fast. Int J Clin Pract 2010; 64(8):1090-4. doi: 10.1111/j.1742-1241.2009.02262.x
14
15. Mafauzy M. Repaglinide versus gliben clamide treatment of type 2 diabetes during Ramadan fasting. Diabets Res Clin Pract 2002; 58(1): 45-53.
15
16. SariR , Balci MK, Akbas SH, AvciB. The effects of diet, sulfonylurea and repaglinide therapy on clinical and metabolic parameters in type 2 diabetic patients during Ramadan. Endocrine Res 2004; 30 (2):169-77.
16
17. Belkahdir J, El Ghomari H, Klocker N, Mikou A, NasciriM, Sabrim. Muslims with non-insulin dependent diabetes fasting during Ramadan: treatment with glibenclamide. BMJ 1993; 307:292-5. doi: 10.1136/bmj.307.6899.292
17
18. Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC.Enzymatic determination of total serum cholesterol. Clin Chem 1974;20 (4):470-5.
18
19. Mennecart M, Mondon K, Malherbe C, Constans T. Delayed hypoglycemia induced by repaglinide in a frail elderly adult with diabetes mellitus. J Am Geriatr Soc 2014; 62(12):2460-2. doi:10.1111/jgs.13144
19
20. Mantovani A, Grani G, Chioma L, Vancieri G, Giordani I, Rendina R, et al. Severe hypoglycemia in patients with known diabetes requiring emergency department care: A report from an Italian multicenter study. J Clin Transl Endocrinol 2016; 5:46-52. doi: 10.1111/jgs.13144
20
21. Kawamori R, Kaku K, Hanafusa T, Ioriya K, Kageyama S, Hotta N. Clinical study of repaglinide efficacy and safety in type 2 diabetes mellitus patients with blood glucose levels inadequately controlled by sitagliptin. J Diabetes Investig 2016; 7(2):253-9. doi:10.1111/jdi.12384
21
22. Bener A, Yousafzai MT. Effect of Ramadan fasting on diabetes mellitus: a population-based study in Qatar. J Egypt Public Health Assoc 2014;89 (2):47-52. doi: 10.1097/01.EPX.0000451852.92252.9b
22
23. M'guil M, Ragala MA, El Guessabi L, Fellat S, Chraibi A, Chebraoui L, et al. Is Ramadan fasting safe in type 2 diabetic patients in view of the lack of significant effect of fasting on clinical and biochemical parameters, blood pressure, and glycemic control?. Clinical and experimental hypertension 2008; 30(5):339-57.
23
24. Bouguerra R, Jabrane J, Maatki C, Salem B, Hamzaoui J, El Kadhi A, et al. Ramadan fasting in type 2 diabetes
24
ORIGINAL_ARTICLE
Epidemiology of malaria in Ramhormoz county, Southwest of Iran, during 2001-2016
Introduction: One of the most important infectious diseases, especially in subtropical and tropical regions in developing countries is Malaria.Due to the importance of the infectious disease in these areas, the aim of current study is to evaluate epidemiology of malaria through microscopic evaluation in Ramhormoz County, southwest of Iran, during 2001-2016. Methods: In this cross-sectional study, the blood specimens were collected from all suspicious malaria individuals referred to the Ramhormoz Healthcare Network. For the preparation of peripheral blood smears, one drop of sample was carefully placed on a microscopic slide and the slide was also stained by the Giemsa staining. In order to the detection of the parasite, the peripheral blood smears were evaluated via optical microscope. Results: In this study, of 2769, 40 (1.44%) individuals were infected to Plasmodium vivax. The highest frequent of malaria was observed in 2001, 2002 with 13 (8.49%) and 11 (6.79%) cases, respectively as well as the lowest prevalence was seen in 2007, 2010, 2012, 2014 and 2015 with nil case. From a total of 40 malaria confirmed cases during the years, 34 (85%) and 6 (15%) were male and female, respectively. Also, of 40, 34 (85%) and 6 (15%) cases were lived in the rural and urban areas, respectively. Conclusion: These findings showed a significant decrease in malaria incidence in Ramhormoz County, southwest of Iran during 2001-2016. Based on the climatic status of the County, the risk of malaria epidemics must be considered constantly and the control programs should be continued until the elimination of disease.
https://www.ijbmph.com/article_61058_ae58505ee6a98d2da0aa0638db1aa80b.pdf
2018-04-27
67
70
10.22631/ijbmph.2018.61058
Epidemiology
Malaria
Plasmodium vivax
Ramhormoz
Forough
Kazemi
forough.kazemi47@gmail.com
1
Department of Parasitology, Faculty of Medicine, Ahvaz Jundishapur University of Medical Science, Ahvaz, Iran.
AUTHOR
Somayeh
Fallahizadeh
somayeh.labratory@gmail.com
2
Department of Parasitology, Faculty of Medicine, Ahvaz Jundishapur University of Medical Science, Ahvaz, Iran.
AUTHOR
Roya
Allasvand
alasvand,roya@yahoo.com
3
Department of Parasitology, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
AUTHOR
Reza
Arjmand
arjmand.reza@yahoo.com
4
Department of Parasitology, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
LEAD_AUTHOR
1. Stevenson JC, Stresman GH, Baidjoe A, Okoth A, Oriango R, Owaga C, et al. Use of different transmission metrics to describe malaria epidemiology in the highlands of western Kenya. Malaria J. 2015; 14(1):418. doi: 10.1186/s12936-015-0944-4
1
2. Cotter C, Sturrock HJ, Hsiang MS, Liu J, Phillips AA, Hwang J, et al. The changing epidemiology of malaria elimination: new strategies for new challenges. The Lancet. 2013; 382(9895):900-11. doi: 10.1016/S0140-6736(13)60310-4
2
3. Del Prado GR, García CH, Cea LM, Espinilla VF, Moreno MF, Marquez AD, et al. Malaria in developing countries. J Infect Dis. 2014; 8(1): 1-4. doi: 10.3855/jidc.4610.
3
4. Salmanzadeh S, Foroutan-Rad M, Khademvatan S, Moogahi S, Bigdeli S. Significant decline of malaria incidence in southwest of Iran (2001–2014). J Trop Med. 2015; 2015.
4
5. Bhatia R, Rastogi RM, Ortega L. Malaria successes and challenges in Asia. J Vector Borne Dis. 2013; 50(4):239-47.
5
6. Halimi M, Delavari M, Takhtardeshir A. Survey of climatic condition of Malaria disease outbreak in Iran using GIS. J School Public Health Institute of Public Health Res. 2013;10(3):41-52.
6
7. Hemami MR, Sari AA, Raeisi A, Vatandoost H, Majdzadeh R. Malaria elimination in iran, importance and challenges. Int J Prev Med. 2013; 4(1):88. PMID: 23413116
7
8. Haghdoost AA, Alexander N, Cox J. Modelling of malaria temporal variations in Iran. Trop Med & Int Health. 2008; 13(12):1501-8. doi: 10.1111/j.1365-3156.2008.02166.x
8
9. Raeisi A, Gouya MM, Nadim A, Ranjbar M, Hasanzehi A, Fallahnezhad M, et al. Determination of malaria epidemiological status in Iran’s malarious areas as baseline information for implementation of malaria elimination program in Iran. Iran J Public Health. 2013; 42(3):326. PMID: 23641411
9
10. Moss WJ, Dorsey G, Mueller I, Laufer MK, Krogstad DJ, Vinetz JM, et al. Malaria epidemiology and control within the international centers of excellence for malaria research. Am J trop Med Hygiene. 2015; 93(3_Suppl):5-15. doi: 10.4269/ajtmh.15-0006
10
11. Sarafraz S, Mehrabani NG, Mirzaei Y, Jafari R, Mehrabani RG, Hayati VR, et al. Epidemiology of malaria in East Azerbaijan province, Iran, from 2001 to 2013. J Parasitic Dis. 2016; 40(3):813-7.
11
12. Soleimanifard S, Akbari M, Sabetghadam M, Saberi S. Malaria Situation in Isfahan in the Last Five Years. J Isfahan Med School. 2011; 29(132).
12
13. Mesdaghinia AR, Vatandoost H, Hanafi-Bojd AA, Majdzadeh R, Raeisi A. Conducting international diploma course on malaria program planning and management (1996–2012). J Arthropod Borne Dis. 2013; 7(2): 100-12. PMID: 24409435
13
14. Zia Sheikholeslami N, Rezaeian M. The retrospective epidemiological study of malaria in Rafsanjan, Kerman province, from 1999 to 2005. J Healt. 2010; 1(1):24-30.
14
15. Saghafipour A, Noroozi M, Karami-Jooshin M, Abbas P. Epidemiological Features of Malaria in Qom province from 2001 to 2011. Zahedan J Res in Med Sci. 2012; 14(8):70-3.
15
16. Khalili MB, Anvari-Tafti M, Sadeh M. Epidemiological pattern of malarial disease in the province of Yazd, Iran (Since 1986-2006). World J Med Sci. 2009;4(1):41-5.
16
17. Alemu A, Muluye D, Mihret M, Adugna M, Gebeyaw M. Ten year trend analysis of malaria prevalence in Kola Diba, North Gondar, Northwest Ethiopia. Parasites & Vectors. 2012; 5(1):173. doi: 10.1186/1756-3305-5-173
17
ORIGINAL_ARTICLE
Study of antibiotic resistance pattern in methicillin-resistant Staphylococcus aureus isolated from clinical samples of hospitals in Tabriz – Iran
Introduction:Methicillin-resistant Staphylococcus aureus (S. aureus) is commonly a cause of nosocomial infections. The increase in infection rates caused by this bacteriain developing countries has led to many problems. The aim of this study is to determine the antibiotic resistance pattern in methicillin-resistant S. aureus strains isolated from clinical specimens. Methods: In this cross-sectional study, 256 isolates of S. aureus were collected from Tabriz hospitals and treatment centers. The isolates were identified by standard laboratory methods and cultured in a specific environment. Identification of Methicillin-Resistant Staphylococcus aureus (MRSA) strains was made through phenotypic method. In order to evaluate antibiotic susceptibility patterns of strains, a disk diffusion method based on CLSI protocol was also performed. Data was analyzed by Chi-square test and SPSS 16 software. Results:Out of 256 examined samples, 197 (76.95%) of them were methicillin-resistant Staphylococcus aureus. The phenotypic evaluation of the antibiotic resistance pattern of methicillin-resistant S. aureus showed that the highest resistance was for 100% penicillin antibiotics, 94.22% co-amoxiclav and 81.22% gentamicin antibiotics and the lowest resistance was observed as chloramphenicol (16.75%). There was no significant relationship between age, sex, and MRSA infections (P> 0.05). Conclusion: High resistance S. aureus to penicillin, co-amoxiclav, gentamicin and also the high frequency of isolation of MRSA of hospital studied samples are remarkable. The present study demonstrates the need for continuous monitoring of antimicrobial susceptibility in S. aureus in order to determine the optimal drug regimens.
https://www.ijbmph.com/article_61059_1e62bf7f7427db6ac52016d77c99ee9a.pdf
2018-04-27
71
75
10.22631/ijbmph.2018.116735.1014
Staphylococcus aureus
Antibiotic Resistance
Methicillin-resistant
Abolfazl
Jafari-Sales
a.jafari_1392@yahoo.com
1
Department of Microbiology, Kazeroon branch, Islamic Azad University, Kazeroon, Iran.
LEAD_AUTHOR
Farhad
Farhadi
a.jafari1391@gmail.com
2
Department of Research and Development, Razi Vaccine and Serum Research Institute, Agricultural Research Education and Extension Organization (AREEO), Karaj, Iran
AUTHOR
Mehdi
Ezdiyadi
taranoom.isi.isc@gmail.com
3
Department of Research and Development, Razi Vaccine and Serum Research Institute, Agricultural Research Education and Extension Organization (AREEO), Karaj, Iran
AUTHOR
Davood
Tarbiat-Nazloo
a.jafari1394@yahoo.com
4
Department of Microbiology, Kazeroon branch, Islamic Azad University, Kazeroon, Iran.
AUTHOR
Nimmo GR, Coombs GW, Pearson JC, O'Brien FG, Christiansen KJ, Turnidge JD, et al. Methicillin-resistant Staphylococcus aureus in the Australian community: an evolving epidemic. Med J Aust 2006; 184(8):384-8.
1
Ostojić M, Hukić M. Genotypic and phenotypic characteristics of Methicillin-resistant Staphylococcus aureus (MRSA) strains, isolated on three different geography locations. Bosn J of Basic Med Sci. 2015; 15(3):48–56. doi:10.17305/bjbms.2015.402
2
Ghaznavi-Rad E, Shamsudin MN, Sekawi Z, Khoon LY, Aziz MN, Hamat RA, et al. Predominance and emergence of clones of hospital-acquired methicillin-resistant S.aureus in Malaysia. J Clin Microbiol. 2010; 48(3):867-72. doi: 10.1128/JCM.01112-09
3
Loewen K, Schreiber Y, Kirlew M, Bocking N, Kelly L. Community-associated methicillin-resistant Staphylococcus aureus infection: Literature review and clinical update. Can Fam Physician. 2017; 63(7):512-520.
4
Graves SF, Kobayashi SD, DeLeo FR. Community-associated methicillin-resistant S. aureus immune evasion and virulence. J Mol Med. 2010; 88(2):109-14.
5
Gutiérrez D, Fernández L, Rodríguez A, García P. Are phage lytic proteins the secret weapon to kill Staphylococcus aureus. MBio. 2018; 9(1):1-17. doi: 10.1128/mBio.01923-17
6
Wilson TJ, Blackledge MS, Vigueira PA. Resensitization of methicillin-resistant Staphylococcus aureus by amoxapine, an FDA-approved antidepressant. Heliyon. 2018; 4(1): e00501. doi:10.1016/j.heliyon.2017.e00501
7
Ghaznavi-Rad E, Shamsudin MN, Sekawi Z, Van Belkum A, Neela V. A simplified multiplex PCR assay for fast and easy discrimination of globally distributed staphylococcal cassette chromosome mec types in meticillin-resistant Staphylococcus aureus. J Med microbial. 2010; 59(10):1135-9. doi:10.1099/jmm.0.021956-0
8
Rajaduraipandi K, Mani K, Panneerselvam K, Mani M, Bhaskar M, Manikandan P. Prevalence and antimicrobial susceptibility pattern of methicillin resistant Staphylococcus aureus: A multicentre study. Indian J Med Microbiol. 2006; 24(1):34-8. doi: 10.4103/0255-0857.19892
9
Dibah S, Arzanlou M, Jannati M, Shapouri R. Prevalence and antimicrobial resistance pattern of methicillin resistant Staphylococcus aureus (MRSA) strains isolated from clinical specimens in Ardabil, Iran. Iran J Microbiol. 2014; 6:163-168. PMID: 25870749
10
Morell EA, Balkin DM. Methicillin-resistant Staphylococcus aureus: A Pervasive Pathogen Highlights the need for new Antimicrobial development. Yale J Biol Med. 2010; 83:223-233. PMCID: PMC3002151
11
Köck R, Becker K, Cookson B, Van Gemert-Pijnen JE, Harbarth S, Kluytmans J, et al. Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe. Euro Surveill. 2010; 15 (41):19688.
12
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: Twenty-second Informational Supplement; Clinical and Laboratory Standards Institute: Wayne, PA, USA: 2012.
13
Forbes BA, Sahm DF, Weissfeld AS. bailey&scotts Diagnostic microbiology. 12th ed. USA; Elsevier 2007; 172-213.
14
Kohner P, Uhl J, Kolbert C, Persing D, Cockerill F. Comparison of susceptibility testing method with mecA gene analysis for determining Oxacillin (Methicillin) resistance in clinical isolate of S. aureus and coagulase negative Staphylococcus spp. J Clin Microbiol. 1999; 37(9):2952-61.
15
Zamani A, Sadeghian S, Ghaderkhani J, Alikhani MY, Najafimosleh M, Taghi Goodarzi M, et al. Detection of methicillin-resistance (mec-A) gene inS. aureus strains by PCR and determination of antibiotic susceptibility. Annals Microbiol. 2007; 57(2):273-6.
16
Moradi N, Javadpour S, Karmostaji A. Reduced sensitivity of S. aureus to vancomycin. HMJ. 2011; 15(3):169-77.
17
Javani E, Falahati H, Sifi M, Talebi M, Ebrahimpor GH, Porshafie M. MecA gene in a strain of S. aureus resistant to oxacillin high from Tehran hospitals. Iranian J Infect Dis and Tropic. 2009; 25:17-22.
18
Haghgoo S, Moaddab S, Rafi A. Study of antibiotic resistance pattern of S. aureus strains isolated from blood cultures in Tabriz Shahid Madani Hospital. Jentashapir J Health Res. 2012; 3(2):383-90.
19
Wang H-K, Huang C-Y, Huang Y-C. Clinical features and molecular characteristics of childhood community-associated methicillin-resistant Staphylococcus aureus infection in a medical center in northern Taiwan, 2012. BMC Infect Dis. 2017; 17:470. doi:10.1186/s12879-017-2560-0
20
Moosavian M, Shahin M, Navidifar T, Torabipour M. Typing of staphylococcal cassette chromosome mec encoding methicillin resistance in Staphylococcus aureus isolates in Ahvaz, Iran. New Microbes New Infect. 2018; 28(21):90-94. doi:10.1016/j.nmni.2017.11.006
21
Udo EE, Al-Sweih R, Dahr TS, Dimitrov EM, Mokaddas M, Johny IA, et al. survaillance of antibacterial resistance in S. aureus isolated in Kuwaiti hospitals. Med Prink Pract. 2008; 17:71-75. doi:10.1159/000109594
22
Mdani TA, Al-Abdollah NA, Al-Sanousi A. Methicillin –Resistant S. aureus in two tertiary-care centers in Jaddah Saudi Arabia. Infect Control Hosp Epidemiol. 2001; 22 (4):211- 216. doi:10.1086/501891
23
Rezazadeh M, Yousefi Mashouf R, Sarmadyan H, Ghaznavi-Rad E. Antibiotic Profile of Methicillin-Resistant S. aureus With Multiple-Drug Resistances Isolated from Nosocomial Infections in Vali-Asr Hospital of Arak. J Arak Uni Med Sci. J 2013; 16 (2):29-37.
24
Parhizgari N, Moosavian S, Sharifi A. Antibiotic resistant pattern of methicillin resistant and sensitive S. aureus isolated from patients durining 2009-2010, Ahvaz, Iran. Armaghane danesh J. 2013;18(9):757-67
25
Askari P, Ghazvini K, Namaee M H, Aryan E, Safdari H, Yousefi M. Prevalence of Methicillin-resistant S. aureus and their antibiotic resistance patterns in patients hospitalized in Birjand-based Imam Reza Hospital. J Birjand Univ Med Sci. 2017;24(3):218-26
26
Vaez H, Ghazi Saeidi K, Moradi A, Tabaraei A, Khodabakhshi B, Bazouri M, et al. Antibiotic resistance pattern of methicillin resistant S. aureus isolated from Health-educational centers of Gorgan, Iran, 2008-2009. Iran J Med Microbiol. 2010; 3(4):31-36.
27
Akanbi OE, Njom HA, Fri J, Otigbu AC, Clarke AM. Antimicrobial Susceptibility of Staphylococcus aureus Isolated from Recreational Waters and Beach Sand in Eastern Cape Province of South Africa. Int J Environ Res Public Health. 2017; 14(9):1001. doi:10.3390/ijerph14091001
28
Ghassemian, R. Najafi N Shojaeifar A. Evaluation of Carriers Staph. aureus in nose thesis. Mazandaran Univ Med Sci J. 2004; 14(44): 79-86.
29
Mohraz M, Jonaidi N, Rasoulinejad M, Broum M A, Aligholi M, Shahsavan Sh. Determination of prevalence of methicillin resistant staphylococcus infections through measurement of mics of S. Aureus isolates Imam hospital (November 2001 To January 2003). Tehran Univ Med J. 2003; 61 (3):182-192.
30
ORIGINAL_ARTICLE
Correlation between type D personality and quality of life in heart failure patients
Introduction: The quality of patient’s life with heart failure is affected by various physiological, psychosocial factors. This study is conducted to determine the correlation between type D personality and quality of life in heart failure patients. Methods: A descriptive correlational research design is planned here. Hundred heart failure patients were selected as sample through convenience sampling from two Social Security Hospitals in Karaj during early February 2012 to late December 2013. The Minnesota Living with Heart Failure Questionnaire (MLHFQ) and type-D personality questionnaire were completed in face-to-face interviews. Data was analyzed by SPSS version 18. Results: Significant correlation were found between type D personality and socioeconomic (r=0.239, P=0.017), mental (r=0.408, P<0.001) and total quality of life (r=0.266, P=0.008). Conclusion: Type D personality in patients with heart failure is associated with poor quality of life. Screening type D personality in heart failure patients and using appropriate interventions can lead to improve the quality of life.
https://www.ijbmph.com/article_61060_516724ad1c1593f4b364ea3bdfb26c58.pdf
2018-04-27
76
81
10.22631/ijbmph.2018.115613.1024
Heart failure
Quality of Life
Type D personality
Sharareh
Zeighami Mohammadi
zeighami@kiau.ac.ir
1
PhD Candidate in Nursing, School of Nursing and Midwifery , Islamic Azad University, Karaj Branch Karaj, Iran.&lrm;
LEAD_AUTHOR
Parvin
Farmani
2
Social Security Alborz Hospital, Karaj, Iran
AUTHOR
Manijeh
Shakoor
3
Social Security Alborz Hospital, Karaj, Iran
AUTHOR
Farzad
Fahidy
4
Social Security Shahriar Hospital, Tehran. Iran
AUTHOR
Ebrahim
Fallah Taherpazir
5
Social Security Shahriar Hospital, Tehran. Iran
AUTHOR
Behnam
Mohseni
6
Social Security Shahriar Hospital, Tehran. Iran
AUTHOR
Savarese G, Lund LH. Global public health burden of heart failure. Card Fail Rev. 2017; 3(1):7-11. doi:10.15420/cfr.2016:25:2
1
Lee JH, Lim N-K, Cho M-C, Park H-Y. Epidemiology of heart failure in Korea: present and future. Korean Circ J. 2016; 46(5):658-64. doi:10.4070/kcj.2016.46.5.658
2
Ziaeian,B Fonarow GC. Epidemiology and aetiology of heart failure. Nat Rev Cardiol. 2016; 13, 368-78.
3
Ahmadi A, Soori H, Mobasheri M, Etemad K, Khaledifar A. Heart Failure, the outcomes, Predictive and related factors in Iran. J Mazandaran Univ Med Sci. 2014; 24 (118):180-8.
4
Travis L, Hardin S, Benton Z, Austin L, Norris L. A nurse-managed population based heart failure clinic: sustaining quality of life. J Nurs Educ Pract. 2012; 2(4):1-8. doi: 10.5430/jnep.v2n4p1
5
Zeighami Mohammadi S, Shahparian M. Quality of life (Qol) and some factors related in males with heart failure in Karaj and Shahriar social security hospitals (2010). J Res Develop Nurs Midwifery. 2012; 8 (2):1-3.
6
Staniute M, Brozaitiene J, Burkauskas J, Kazukauskiene N, Mickuviene N, Bunevicius R. Type D personality, mental distress, social support and health-related quality of life in coronary artery disease patients with heart failure: a longitudinal observational study. Health Qual Life Out. 2015; 22; 13:1. doi: 10.1186/s12955-014-0204-2
7
Abedi HA, Yasaman-Alipour M, Abdeyazdan G. Quality of Life in heart failure patients referred to the Kerman outpatient centers, 2010. J Shahrekord Univ Med Sci. 2011; 13 (5):55-63.
8
Yousefi P, Sabzevari S, Alizadeh SM, Haghdoost A. Study of quality of life in heart failure hospitalized patients in Kerman medical university hospital in 2008. Iranian J Nurs Res. 2011; 6 (21):59-67.
9
Eskandari S, Heravi-Karimooi M, Rejeh N, Ebadi A, Taheri Kharameh Z, Montazeri A. Quality of life in heart failure patients using the Minnesota Living with Heart Failure Questionnaire (MLHF). Payesh. 2016; 15(5): 559-66.
10
Wu J-R, Lennie TA, Frazier SK, Moser DK. Health-related quality of Life, functional status and cardiac event-free survival in patients with heart failure. J Cardiovasc Nurs. 2016; 31(3):236-44. doi:10.1097/JCN.0000000000000248
11
Nasiry Zarrin Ghabaee D, Saber Moghadam Ranjbar M, Bagheri Nesami M, Haresabadi M. Relationship between mental health and quality of life in patients with heart failure. Iranian J Rehabilitation Res. 2015; 1 (4):21-30. doi: 10.21859/ijrn-04025
12
Heidarzadeh M, Hasani P, Rahimzadeh A, Ghahramanian A, Kolahdouzi Pour J, Yousefi I. Quality of life and social support in congestive heart failure patients and healthy people. J Holist Nurs Midwifery. 2013; 23 (1):13-21.
13
Svansdottir E, Van Den Broek KC, Karlsson HD, Gudnason T, Denollet J. Type D personality is associated with impaired psychological status and unhealthy lifestyle in Icelandic cardiac patients: a cross-sectional study. BMC Public Health. 2012; 12(1): 42. doi: 10.1186/1471-2458-12-42.
14
Zeighami Mohammadi S, Danesh E, Farmani P, Shakoor M, Fahidy F, Mohseni B ,et al . Correlation between type D personality and adherence to low-sodium diet in patients with systolic heart failure. Qom Uni Med Sci J. 2017; 11 (4):32-42.
15
Tziallas D, Kostapanos MS, Skapinakis P, Milionis HJ, Athanasiou T, Elisaf MS, et al. The association between Type D personality and the metabolic syndrome: a cross-sectional study in a University-based outpatient lipid clinic. BMC Res Notes. 2011; 4(1):105. doi: 10.1186/1756-0500-4-105
16
Pedersen SS, Herrmann-Lingen C, De Jonge P, Scherer M. Type D personality is a predictor of poor emotional quality of life in primary care heart failure patients independent of depressive symptoms and New York Heart Association functional class. J Behav Med. 2010; 33(1):72-80.
17
Brace N, Kemp R, Snelger R. Spss for psychologist: a guide to data analysis using SPSS for windows. Palgrave Macmillan; London; 3 ed. 2007.
18
Piepoli MF, Hoes AW, Agewall S, Agewall S, Albus C, Brotons C, et al. 2016 European guidelines on cardiovascular disease prevention in clinical practice: the sixth joint task force of the european society of cardiology and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) developed with the special contribution of the european association for cardiovascular prevention & rehabilitation (EACPR). Eur Heart J. 2016; 37(29):2315-81. doi: 10.1093/eurheartj/ehw106
19
Ahmadpour AR, Ahadi H, Mazaheri MM, Nafissi GH. Construction and scale validation for evaluating type D personality and a study of its relationship to the coronary heart disease. Knowledge Res Appl Psychol. 2007; 9(32):37-60.
20
Behlouli H, Feldman DE, Ducharme A, Frenette M, Giannetti N, Grondin F, et al. Identifying relative cut-off scores with neural networks for interpretation of the Minnesota Living with Heart Failure questionnaire. Conf Proc IEEE Eng Med Biol Soc. 2009;2009:6242-6. doi:10.1109/IEMBS.2009.5334659
21
Eskandari S, Heravi-Karimooi M, Rejeh N, Ebadi A, Montazeri A. Translation and validation study of the Iranian version of minnesota living with heart failure questionnaire. Payesh J. 2015; 14 (4):475 - 84.
22
Pelle AJ, Schiffer AA, Smith OR, Widdershoven JW, Denollet J. Inadequate consultation behavior modulates the relationship between type D personality and impaired health status in chronic heart failure. Int J Cardiol. 2010; 142(1):65-71. doi:10.1016/j.ijcard.2008.12.086
23
Schiffer AA, Denollet J, Widdershoven JW, Hendriks EH, Smith OR. Failure to consult for symptoms of heart failure in patients with a type-D personality. Heart. 2007; 93(7):814-8. doi:10.1136/hrt.2006.102822
24
Schiffer AA, Pedersen SS, Broers H, Widdershoven JW, Denollet J. Type-D personality but not depression predicts severity of anxiety in heart failure patients at 1-year follow-up. J Affect Disord. 2008; 106(1-2):73-81.
25
Schiffer AA, Pedersen SS, Widdershoven JW, Hendriks EH, Winter JB, Denollet J. The distressed (type D) personality is independently associated with impaired health status and increased depressive symptoms in chronic heart failure. Eur J Cardiovasc Prev Rehabil. 2005; 12(4):341-6.
26
Chung ML, Mosor DK, Lennie TA, Frazier SK. Perceived social support predicted quality of life in patients with heart failure, but the effect is mediated by depressive symptoms. Qual Life Res. 2013; 22(7):1555-63.
27
Wu J-R, Moser DK. Type D personality predicts poor medication adherence in patients with heart failure in the USA. Int J Behav Med. 2014; 21(5):833-42.
28
Mommersteeg PM, Pelle AJ, Ramakers C, Szabo BM, Denollet J, Kupper N. Type D personality and course of health status over 18 months in outpatients with heart failure: multiple mediating inflammatory biomarkers. Brain Behav Immun. 2012; 26(2):301-10.
29
Oginska-Bulik N. Type D personality and quality of life in subjects after myocardial infarction. Kardiol Pol. 2014; 72(7):624-30.
30
ORIGINAL_ARTICLE
Implementation of the integrated educational model on the cognitive and psychological competence in nursing students
Introduction: Since the nurse is the most important member of the medical staff, their cognitive and psychological ability to improve the quality of patient care is essential, so, this study was conducted to determine the effect of integrated educational model on cognitive and psychological competence of nursing students. Methods: In this quasi-experimental research, the designed educational model is a combination of three methods of group discussion, problem solving, and the use of conceptual maps. In this process, the sampling was done at Imam Khomeini Hospital in Kermanshah in the first half of 2017-2018, and 60 nursing students entered the study. The students' information about nursing care was in burn patients and data were analyzed by IBM SPSS 22. Results: In this study, the mean age of students was 20.54±14.16 years and most of them (55%) were female students. Pretest and posttest scores in cognitive areas were significantly different (Based on frequency and frequency percent). The other results showed that the level of knowledge and cognitive ability of students after intervention was improved (p≤0.05). Conclusion: The present study demonstrates the effect of integrated training on knowledge and skills of nursing students in burn ward, it is suggested this method can be used in these sections as well as conducting other researches on this approach in various nursing settings.
https://www.ijbmph.com/article_62641_ead30a0b349ce2182f5b983b6d6c8232.pdf
2018-05-17
82
88
10.22631/ijbmph.2018.125516.1044
problem solving
Nursing
Students
Education
Burn units
Alireza
Abdi
a_abdi61@yahoo.com
1
Assistant Professor, Nursing Department, School of Nursing and midwifery, Kermanshah University of Medical Sciences, Kermanshah, Iran
LEAD_AUTHOR
Saba
Karimi
kariminursing@yahoo.com
2
School of Nursing and Midwifery, Kermanshah University of Medical Sciences, Kermanshah, Iran.
AUTHOR
Vahabi S, Ebadi A, Rahmani R, Tavallaei A, Khatouni A, Tadrisi S, et al. Comparison of the status of clinical education in the views of nursing educators and students. Educ Strategies Med Sci. 2011;3(4):179-82.
1
Mirzabeigi G, Sanjari M, Shirazi F, Haidari S, Salemi S. Nursing students' and educators' views about nursing education in Iran. Iranian J Nurs Res. 2011;6(20):64-74.
2
OshvandiKh, Pouryousef S, Bikmoradi A. The Effects of Inquiry Based Clinical nstruction of Nursing Students on Applying Nursing Process Skill. Sci J Hamadan Nurs Midwifery Fac. 2013; 21(1): 5 -15.
3
Tavakoli M, Khazaei T, Tolyat M, Ghorbani S. The Quality of clinical education from the viewpoints of students and instructors of paramedical and nursing-obstetrics schools of Birjand University of Medical Sciences. Sci Res J Shahed Univ. 2014; 21(110):41-8.
4
Ramezani Fir M, Kermanshahi S. A survey of the quality of clinical education in nursing. J Jahrom Univ Med Sci. 2011; 9(1):14-21.
5
Ghafourifard M, Bayandor A, Zirak M. Clinical education status in educational centers affiliated to Zanjan University of medical sciences from viewpoints of nursing and midwifery students. J Educ Dev Janjan Med Sci. 2016; 20(8):8-19.
6
Fotoukian Z, Hosseini SJ, Beheshti Z, Zabihi A, Aziznejad P, Ghaffari F. [Clinical education status according to the nursing students' point of view, Babol Medical Sciences University]. Bian J Med Educ Dev Cent. 2013; 1(1):26-33.
7
Orujlu S, HemmatiMaslak Pak M, KHalkhali H. The Effect of Problem Solving Education in Fourth-year nursing Student’ Views of success. J Urmia Nurs Midwifery Fac. 2013; 11 (3):212-7.
8
Asgari F, Khoshnazar T, Sedighi A. Comparison of efficiency management training using lecturing and small group teaching on learning rate of Nursing and Midwifery student’s. J Holist Nurs Midwifery. 2015; 25 (1):26-34.
9
Aein F, Frouzandeh N. Investigating efficacy of concept mapping in student’s learning of nursing process of pediatric patients. J Shahrekord Univ Med Sci. 2012; 14 (2):55-63.
10
Mansoori S, Abedini-baltork M, Lashkari H, Bagheri S. Effectiveness of Problem-Based Learning on Student's Academic Performance: A quasi-experimental study. Res in Med Edu. 2017; 9 (1) :8-1
11
Lake D. Student performance and perceptions of a lecture-based course compared with the same course utilizing group discussion. Phys Ther. 2001;81(3):896-902. doi: 10.1093/ptj/81.3.896
12
Materna L. Impact of Concept-mapping Upon Meaningful Learning and Metacognition Among Foundation Level Associate-degree Nursing Students. [dissertation]. USA: Capella University; 2000.
13
. Sarhangi F, Masumi M, Ebadi A, Mazhari M, Rahmani A. Comparing the effect of lecture- and concept mapping based learning on cognitive learning levels. Iranian J Critical Care Nurs. 2010; 3(1): 1-5.
14
Ghanbari A, Paryad E, Ehsani M. The Effectiveness of Conceptual Map Teaching Method on Short and Long Term Learning in Nursing Students. Strides Dev Med Educ. 2011; 7 (2) :112-118.
15
August-Brady MM. The effect of a metacognitive intervention on approach to and self-regulation of learning in baccalaureate nursing students. J Nurs Educ. 2005; 44(7): 297-304.
16
Rasouli M, Rasouli A, Kalhor N. Comparing Lecture and Problem-based Learning Methods in Teaching Gastrointestinal Part of Patients' Health Assessment on Nursing Students’ Knowledge and Their Performance. J Nurs Educ. 2017; 6 (5):25-31.
17
Jabbari H, Bakhshian F, Alizadeh M, AlikhahH, Naghavi Behzad M. Lecture-based versus problem-based learning methods in public health course for medical students. Res Dev Med Educ. 2012; 1(2):31-5. doi: 10.5681/rdme.2012.008
18
ChakravarthiS, Haleagrahara N. Implementation of PBL curriculum involving multiple disciplines in undergraduate medical education programme. Int Educ Stud. 2010; 3(1):165-9.
19
Meo SA. Evaluating learning among undergraduate medical students in schools with traditional and problem-based curricula. Adv Physiol Educ. 2013; 37(3):249-53. doi: 10.1152/advan.00031.2013.
20
ORIGINAL_ARTICLE
Spatial pattern of phenylketonuria disease determination using geographic information system in Lorestan province from 2006 to 2016
Introduction: Phenylketonuria(PKU) is a metabolic disorder that, if not detected and treated promptly, causes mental retardation. The use of the geographic information system (GIS) in favor of spreading the disease helps to control the disease. Therefore, the aim of this study was to determine the local pattern of the PKU disease using the GIS in Lorestan province from 2006 to 2016. Methods: The current descriptive cross-sectional study was conducted on the patients diagnosed with PKU in Lorestan province from 2006 to 2016. The statistical population included all cases identified between April 2006 and March 2016. The ArcGIS 9.3 software was used to provide geographic maps of the incidence and frequency of the disease. Results: The results showed that Nourabad county had the highest number of larvae with 22 (72.29%), and the most cases with PKU disease were with 2 cases (99.2%). According to GIS maps, the incidence of PKU from 2006 to 2016 was on an ascending tide. The highest incidence in these years was related to Nurabad with an average of 5.7 per 10,000 live births and the lowest incidence related to Boroujerd county with more than 0.53 per 10,000 live births. Conclusion: According to the GIS map, Nourabad county has the highest incidence of PKU. Therefore, it is necessary to consider the majority of prevention programs for paternity screening and counseling couples, especially family marriages in the city, in order to reduce the incidence of this disease.
https://www.ijbmph.com/article_67157_b100ff2db90ab3d008fa7e442d07ab0f.pdf
2018-05-15
89
94
10.22631/ijbmph.2018.121546.1033
Incidence
Phenylketonuria
Iran
Zaher
Khazaei
zaherkhazaei@yahoo.com
1
1. Department of Public Health, School of Health, Sabzevar University of Medical Sciences, Sabzevar, Iran
LEAD_AUTHOR
Yousef
Moradi
2
Pars Advanced and Minimally Invasive Medical Manners Research Center, Pars Hospital, Iran University of Medical Science, Tehran, Iran
AUTHOR
Golnaz
Sharifnia
3
Departments of Epidemiology, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
AUTHOR
Mojgan
Navabi
4
Department of Diseases, Health Network, Borujerd, Borujerd, Iran
AUTHOR
Malihe
Sohrabivafa
5
Department of Health and Community Medicine, Faculty of Medicine, Dezful University of Medical Sciences, Dezful, Iran
AUTHOR
Elham
Goodarzi
elhamgoodarzi.1370@yahoo.com
6
Social Determinants of Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran
AUTHOR
1. Bernstein L, Burns C, Sailer-Hammons M, Kurtz A, Rohr F. Multiclinic Observations on the Simplified Diet in PKU. J Clin Nutr Metab. 2017; 2017:1-5. doi:10.1155/2017/4083293
1
2. Senemar S, Ganjekarimi H, Fathzadeh M, Tarami B, Bazrgar M. Epidemiological and clinical study of Phenylketonuria (PKU) disease in the National Screening Program of Neonates, Fars province, Southern Iran. Iran J Public Health. 2009;38(2):58-64.
2
3. Eijgelshoven I, Demirdas S, Smith TA, Van Loon JM, Latour S, Bosch AM. The time consuming nature of phenylketonuria: a cross-sectional study investigating time burden and costs of phenylketonuria in the Netherlands. Mol Genet Metab Rep. 2013; 109(3):237-42. doi:10.1016/j.ymgme.2013.05.003
3
4. Goodarzi E, Ghaderi E, Khazaei S, Alikhani A, Ghavi S, Mansori K, et al. The prevalence of transient and permanent congenital hypothyroidism in infants of Kurdistan Province, Iran (2006-2014). Int J Pediatr. 2017; 5(2):4309-18. doi:10.22038/ijp.2016.7902
4
5. Etemad K, Khazaei Z, Pordanjani SR, Shahsavand M, Ajam F, Riahi S-M, et al. Evaluation of the therapeutic interventions effects on body growth pattern of infants with congenital hypothyroidism. Biomed Res Ther. 2018; 5(4):2194-207. doi:10.15419/bmrat.v5i4.433
5
6. Kono K, Okano Y, Nakayama K, Hase Y, Minamikawa S, Ozawa N, et al. Diffusion-weighted MR imaging in patients with phenylketonuria: relationship between serum phenylalanine levels and ADC values in cerebral white matter. Radiology. 2005; 236(2):630-6. doi:10.1148/radiol.2362040611
6
7. Moradi K, Alibakhshi R. High risk of birth defects with PKU in Mast-e Ali village, Kermanshah province. J Kermanshah Univ Med Sci. 2014; 18(1):62-5.
7
8. Dos Santos LL, De Castro Magalhães M, De Oliveira Reis A, Starling ALP, Januário JN, da Fonseca CG, et al. Frequencies of phenylalanine hydroxylase mutations I65T, R252W, R261Q, R261X, IVS10nt11, V388M, R408W, Y414C, and IVS12nt1 in Minas Gerais, Brazil. Genet Mol Res. 2006; 5(1):16-23. PMID:16755493
8
9. Motamedi N, Goodarzi E, Pordanjani SR, Valizadeh R, Moradi Y, Sohrabivafa M, et al. Incidence of phenylketonuria in Lorestan province, West of Iran (2006-2016). Int J Pediatr. 2017; 5(40):4713-21. doi:10.22038/ijp.2017.21094.1770
9
10. Sipe NG, Dale P. Challenges in using geographic information systems (GIS) to understand and control malaria in Indonesia. Malar J. 2003; 2(1):36-44. doi:10.1186/1475-2875-2-36
10
11. Seif A, Rashidi M, Rozbahani R, Daheshti N, Poursafa P. GIS application in medical researches a solution for prevention from disease. J Esfahan Univ Med Sci. 2011;29(164):1-10.
11
12. Tanser FC, Le Sueur D. The application of geographical information systems to important public health problems in Africa. Int J Health Geogr. 2002; 1(1):4-13. doi:10.1186/1476-072X-1-4
12
13. Hassan A, Kenawy M, Kamal H, Abdel Sattar A, Sowilem M. GIS-based prediction of malaria risk in Egypt. East Mediterr Health J. 2003; 9 (4), 548-558.
13
14. Boulos MK, Roudsari AV, Carson ER. Health geomatics: an enabling suite of technologies in health and healthcare. J Biomed Inform. 2001; 34(3):195-219. doi:10.1006/jbin.2001.1015
14
15. Magruder C, Burke M, Hann NE, Ludovic JA. Using information technology to improve the public health system. J Public Health Manag Pract. 2005; 11(2):123-30.
15
16. Habib A, Fallahzadeh MH, Kazeroni HR, Ganjkarimi AH. Incidence of phenylketonuria in Southern Iran. Iran J Med Sci. 2010; 35(2):137.
16
17. Badiee S, Morovatdar N, Hossini SMR, Norouzi F, Mina T. Epidemiological and clinical study of phenylketonouria (PKU) disease in Khorasan Province; Northeast Iran. Med J Mashhad Univ Med Sci. 2014; 57(3):571-8.
17
18. Madden M. Phenylketonuria: Defects in amino acid metabolism. Mol Med (SCJMM). 2004;5:57-61.
18
19. Kabiri M. A Report on the Incidence of phenylketonuria. Acta Medica Iranica. 1982;24(3-4):107-13.
19
20. Depatement G. Center of Noncommunicable Disease. Prevention and Control of Phenylketonuria Guideline. 2011:4-5.
20
21. Moradi P, Sari-Sarraf B, Khamnian Z, Dolatkhah R, Hadi S, Ghafari D, et al. Distribution Occurrence of Phenylketonuria in the World: A Systematic Review and Meta-Analysis. Depiction Health. 2016;6(4):1-12.
21
22. Koochmeshgi J, Bagheri A, Hosseini-Mazinani S. Incidence of phenylketonuria in Iran estimated from consanguineous marriages. J Inherit Metab Dis. 2002; 25(1):80-1. doi:10.1023/A:1015154321142
22
23. Pangkanon S CW, Janejai N, Boonwanich W, Chaisomchit S. Detection of phenylketonuria by the newborn screening program in Thailand. Southeast Asian J Trop Med Public Health. 2009; 40(3):525-9. PMID:19842439
23
24. Senemar SA, Ganjekarimi H, Fathzadeh M, Tarami B, Bazrgar M. Epidemiological and clinical study of Phenylketonuria (PKU) disease in the National Screening Program of Neonates, Fars province, Southern Iran. Iran J Public Health. 2009; 38(2):58-64.
24
ORIGINAL_ARTICLE
A comparative study on the effect of the California Book and relative value of services on the costs of hospitalization for common surgeries in selected hospitals of Sanandaj, Iran
Introduction:Tariff determination is one of the important tools for policy making which governments use to intervene in the health market. The aim of this study was to compare California Book effect and relative value of services on the costs of hospitalization for common surgeries in selected hospitals of Sanandaj, Iran before and after the implementation of National Healthcare Reform Program (NHRP). Methods: This semi-experimental study using before and after method was conducted on medical records of patients underwent surgeries in Tohid and Besat hospitals, Sanandaj, Iran that insured by Iran Health Insurance Organization in 2015. Data were collected from medical records of patients who underwent surgeries including; cataract, tonsillectomy-adenoidectomy, pilonidal sinus, cholecystectomy, delivery, cesarean section, curettage, abortion, appendectomy and anterior-posterior colporraphy. The data included the total cost, organization share, and patient share, the share of subsidies, out-of commitment and final payment. Results:After the implementation of National Healthcare Reform Program the average cost of common surgical procedures showed 80.8% growth. The highest average growth rate of organization share was for abortion with 125.1% growth and the lowest average growth rate of organization share was for anterior-posterior colporraphy with 46.3% growth. In terms of the share of subsidies anterior-posterior colporraphy with 299.8% had the highest and delivery with a negative growth of 7.6% had the lowest share of the subsidies. Conclusion: After the implementation of National Healthcare Reform Program the cost of surgery has doubled and additional burden has been inflicted on the health insurance organization to contribute the organization's share. Therefore, the organization's commitment to public and private health service providers was delayed.
https://www.ijbmph.com/article_61061_f14c7999284a57e16fbef2f2fac113bc.pdf
2018-04-27
95
100
10.22631/ijbmph.2018.120156.1026
National Healthcare Reform Program
Relative Value of Services
California Book
Parvin
Haydari
haydariparvin@gmail.com
1
Bs in Nursing, Iran Health Insurance Organization of Kurdistan, Sanandaj, Iran
LEAD_AUTHOR
1. The World Health Report 2010: Health Systems Financing; the Path to Universal Coverage 2010. Available at:http://apps.who.int/iris/bitstream/10665/44371/1/978924 1564021_eng. pdf, access dat: 4/6/2016
1
2. Babashahy S, Akbari Sari A, Rashidian A, Olyaee Manesh A. Payments of Physicians Employed in Public and Private Hospitals after Modification of Surgical and Invasive Services Tariffs. Hakim Research Journal 2012; 15(1): 38- 43.
2
3. World Health Organization. The World health report: 2000: Health systems: improving performance 2000. Available at: http://www.who.int/whr/2000/en/whr00_en.pdf
3
4. Frenk J. Leading the way towards universal health coverage: a call to action. Lancet. 2015; 385(9975):1352-8. doi:10.1016/S0140-6736(14)61467-7
4
5. Cheng TL, Goodman E, Committee on Pediatric Research. Race, ethnicity and socioeconomic status in research on child health. J Pediatr. 2015; 135(1):e225-37. doi:10.1542/peds.2014-3109
5
6. Shariati M. Reforms the health system, Why and how?. J Knowl Health. 2010; 5(2):20-1. doi:10.22100/jkh.v5i0.957
6
7. Hashemi B, Baratloo A, Forouzafar MM, Motamedi M, Tarkhorani M. Patient Satisfaction Before and After Executing Health Sector Evolution Plan. Iran J Emerg Med. 2015; 2(3):127-33.
7
8. shahraki M, Ghaderi S. The impact of Education and Health Infrastructures on Economic Growth of Iran. Quart J Eco Growth Develop Res. 2014; 5(19):117-3
8
9. Rasidian A, Doshmangir L. Substitution of ‘California’ book, the First Clinical and Diagnosis Tariff Reference book in Iran: Expert’s View Points. Med cultivat Res J. 2013;22(3):59-78.
9
10. Emami Razavi SH. Health system reform plan in Iran: Approaching Universal Health Coverage. Hakim Health Sys Res. 2016; 18 (4):329-35
10
11. Khojasteh A. The strengths and weaknesses of the healthcare reform plan: Mehr News; 2015 [updated 20162015]. Available from: www.mehrnews.com/news/2365802.
11
12. Nejati MH. The health system said goodbye to California book. Shargh news paper; 2016:2129
12
13. Nasri M. A comparative study of the California book effect and the servicesrelative value on inpatient costs of the common actions in the selected hospitals of ILAM city in September and October 2014. J Ilam Univ Med Sci. 2017; 25 (1):169-79. doi:10.29252/sjimu.25.1.169
13
14. Doshmangir L, Rashidian A, Moaeiri F, Akbari Salari A. Effect of Proposed Changes of Relative Values of Different Specialists Medical Tariffs on Payment Weight to Specialties and Health System Costs. Hakim Health Sys Res. 2011; 14 (1):1-9
14
15. Alidadi A, Amerioun A, Sepandi M, Hosseini Shokouh S M, Abedi R, Zibadel L, et al. The Opportunities and Challenges of the Ministry of Health and Medical Education for Improvement of Healthcare System. Health Res J. 2016; 1 (3):173-84.
15
doi:10.18869/acadpub.hrjbaq.1.3.179
16
16. Zare H, Akhavan Behbahani A, Azadi M, Irvan masoudi A. Assessment of Methods for Determination of Medical Tariffs in Developed Countries and Proposing a Model for Iran. Majlis Rahbord. 2013; 20(74): 5-34
17
17. Piroozi B, Moradi G, Nouri B, MohamadiB olbanabad A, Safari H. Catastrophic Health Expenditure After the Implementation of Health Sector Evolution Plan: A Case Study in the West of Iran. Int J Health Policy Manag 2016; 5(7): 417-23. doi:10.15171/ijhpm.2016.31
18
ORIGINAL_ARTICLE
Evaluation of health and treatment indicators of the private clinics of Bandar Abbas city according to the national standards in 2016
Introduction: Private clinics are one of the most important providers of health services that play a special role in the physical and mental health of patients and also in improving the health level of the community, the aim of this study was to determine the health and treatment indicators of private clinics in Bandar Abbas city based on national standards in 2017. Methods: In this cross-sectional study, the study population was 80 specialized physicians, surgeons, and dentists’ clinics in Bandar Abbas. Data was collected by using a standard checklist including health and treatment indicators. The data were analyzed using descriptive statistics methods in SPSS 16 software. Results: In terms of treatment indicators, radiology and ultrasonography clinics received the highest score (61.5 out of 69) and the lowest score was for specialized pulmonology clinics (55). In terms of health indicators, the highest scores were for specialized gynecology clinics (27.9 out of 33), pulmonology (27) and psychiatric (27), while the lowest score was for ultrasonography and radiology (23.6), internist and dermatology (24). Conclusion: According to the results, training on health standards provided by the Ministry of Health and Medical Education will help to increase the level of health and treatment services in clinics in Bandar Abbas.
https://www.ijbmph.com/article_61767_d462169ff817855f5fc69068eede6663.pdf
2018-05-09
101
107
10.22631/ijbmph.2018.121649.1035
Clinic
Health Indicators
Treatment Indicators
Narges
Hashemi
setare137093@yahoo.com
1
MSC Student of Nursing, Student Research Committee, Hormozgan University of Medical Sciences, BandarAbbas, Iran.
AUTHOR
Zoha
Heidarinejad
z_heidarinejad@yahoo.com
2
MSC Student of Environmental Health Engineering, Student Research Committee, Faculty of Health, Hormozgan University of Medical Science, Bandar Abbas, Iran
LEAD_AUTHOR
Babak
Goodarzi
babakgoodarzi_557@yahoo.com
3
Lecturer, Department of Environmental Health Engineering, Faculty of Health, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
AUTHOR
Ghorbani Nia R, Ahmadian KH, Ranjbar Z. To Compare the Performance Indexes of Selected Hospital with National Standards. Journal of Health Promotion Management. 2017; 7(3): 1-7.DOI: 10.21859/jhpm-07031
1
Amerioun A, Tofighi S, Mahdavi S, Mamaghani H, Meskarpour Amiri M. Assessment of International Joint Commission (IJC) accreditation standard in a military hospital laboratory. Iranian J Mil Med. 2011;13(2):75-80.
2
Jonidi Jafari A, Golbaz S, Sajjadi HS. The study of environmental hygiene indexes status in Karaj Hospitals: 2011. J Hospital 2012; 10(4): 9-18.
3
Alihoseini N, Ravanipour M, Motamed N, Mohammadi Baghmolaei M. Assessment the environmental health status of private clinics, laboratories and Radiologies of Bushehr in 2012. Iranian South Medical Journal. 2016; 19(2):284-295. DOI:10.18869/acadpub.ismj.19.2.284
4
Pasquarella C, Veronesi L, Castiglia P, et al. Italian multicentre study on microbial environmental contamination in dental clinics: a pilot study. Sci Total Environ 2010; 408: 4045-51. DOI.org/10.1016/j.scitotenv.2010.05.010
5
Goodarzi B, HahsemiN, Heidarinejad Z. Survey of health and Protection status of radiology centers of Bandar Abbas city in 2016. Journal of Preventive Medicine 2017; 4(2):50-59.
6
Fadaei A. Comparison of Environmental Health Indices of Private Clinics in Chramahal and Bakhtiari Province, Iran. Adv Environ Biol. 2014; 8: 2335-38.
7
Mehdipour Rabori M, Khalooei A, Nakhaei Amroudi N, Nourmoradi H. Compliance with Environmental Health Standards in Educational Hospitals of Kerman University of Medical Sciences in 2009. Journal of Health. 2013; 5(2): 159-169.
8
Razghandi F, Molazem Alhoseini R, Khamirchi Ramezan A, Hoshmand R. The Status of Environmental Hygiene Indexes in Sabzevar Educational Hospitals: 2014. Beyhagh; 2016; 21(36): 60-6.
9
Hosseinpoor S. Investigating Status of Environmental and Structural Health Indicators Among Therapeutic and Educational Hospitals of Urmia, in 2016. J Urmia Nurs Midwifery Fac. 2017; 15(1): 58-66.
10
Salimi M, Arab M, Akbari F, Zeraati H, Farzianpoor F. A survey on the status of environmental health management in Qom province hospitals. Journal of School of Public Health and Institute of Public Health Research 2007;5(3):59-66.
11
ORIGINAL_ARTICLE
Performance characteristics of single-cylinder spark-ignition engine and its pollutant emissions by using methanol and ethanol fuel blended with gasoline
Introduction:Increasing air pollution is one of the problems of living in large cities. Motor vehicles are the main source of emissions of these pollutants. Petroleum derivatives, especially gasoline, are the most important fuel for internal combustion engines. The fuel consumption of these engines causes excess emissions of pollutants such as carbon monoxide, carbon dioxide, sulfur oxides and nitrogen oxides. Therefore, the use of an alternative fuel seems necessary. The aim of this study was to investigate performance characteristics of single-cylinder spark-ignition engine and its pollutant emissions by using methanol and ethanol fuel blended with gasoline. Methods: In this study, Honda single-cylinder four-stroke engine was used. Gasoline was prepared from the locations of the National Oil Distribution Company and separately mixed with methanol and ethanol in different proportions. The tests were performed at 2 engine speeds including 2000 and 4000 rpm. Obtained data were analyzed by SPSS 16. Results:The results showed that the combination of methanol fuel with gasoline in variable proportions produced less pollutant at low engine speed compared to that of ethanol fuel. Similarly, this result was also observed at high engine speed. Therefore, methanol fuel is more suitable as an alternative to fossil fuels such as gasoline in terms of emission of pollutants. Regarding the average amount of total emissions resulted from consumption of alternative fuels combined with gasoline, it can be said that the amount of pollutant production decreases with increasing methanol and ethanol content. Conclusion: The use of methanol and ethanol as an alternative fuel to gasoline in automobiles reduces pollutant emissions Therefore, the problem of pollutants produced by gasoline engines can be significantly reduced through replacing gasoline by ethanol and methanol, and this replacement can result in improvement of health and satisfaction of the people.
https://www.ijbmph.com/article_69920_c19368ba5c699d24075f2c3a689c71cd.pdf
2018-05-20
108
113
10.22631/ijbmph.2018.144689.1072
Ethanol
Methanol
Motor bike
Fuel
Ramazan Ali
Dianati Tilaki
1
Department of Environmental Health Engineering, Health Sciences Research Center, Faculty of Health, Mazandaran University of Medical Sciences, Sari, Iran.
AUTHOR
Houssein
Chabok
2
Student of Environmental Health Engineering, Student Research Committee, Faculty of Health, Mazandaran University of Medical Sciences, Sari, Iran.
LEAD_AUTHOR
Reza
Sadeghnezhad
rezasadeghnezhad7@gmail.com
3
Student of Environmental Health Engineering, Student Research Committee, Faculty of Health, Mazandaran University of Medical Sciences, Sari, Iran.
AUTHOR
1. Kwanchareon P, Luengnaruemitchai A, Jai-In S. Solubility of a diesel–biodiesel–ethanol blend, its fuel properties, and its emission characteristics from diesel engine. Fuel. 2007;86(7-8):1053-61.
1
2. Kumar MS, Kerihuel A, Bellettre J, Tazerout M. Ethanol animal fat emulsions as a diesel engine fuel–part 2: engine test analysis. Fuel. 2006;85(17-18):2646-52.
2
3. Qi D, Chen H, Geng L, Bian Y. Effect of diethyl ether and ethanol additives on the combustion and emission characteristics of biodiesel-diesel blended fuel engine. Renewable energy. 2011;36(4):1252-8.
3
4. Sheehan J, Aden A, Paustian K, Killian K, Brenner J, Walsh M, et al. Energy and environmental aspects of using corn stover for fuel ethanol. Journal of Industrial Ecology. 2003;7(3‐4):117-46.
4
5. Xing-cai L, Jian-Guang Y, Wu-Gao Z, Zhen H. Effect of cetane number improver on heat release rate and emissions of high speed diesel engine fueled with ethanol–diesel blend fuel. Fuel. 2004;83(14-15):2013-20.
5
6. Hansen AC, Zhang Q, Lyne PW. Ethanol–diesel fuel blends––a review. Bioresource technology. 2005;96(3):277-85.
6
7. Rakopoulos D, Rakopoulos C, Kakaras E, Giakoumis E. Effects of ethanol–diesel fuel blends on the performance and exhaust emissions of heavy duty DI diesel engine. Energy Conversion and Management. 2008;49(11):3155-62.
7
8. Shi X, Yu Y, He H, Shuai S, Wang J, Li R. Emission characteristics using methyl soyate–ethanol–diesel fuel blends on a diesel engine. Fuel. 2005;84(12-13):1543-9.
8
9. Ajav E, Singh B, Bhattacharya T. Experimental study of some performance parameters of a constant speed stationary diesel engine using ethanol–diesel blends as fuel. Biomass and Bioenergy. 1999;17(4):357-65.
9
10. Yüksel F, Yüksel B. The use of ethanol–gasoline blend as a fuel in an SI engine. Renewable energy. 2004;29(7):1181-91.
10
11. Shi X, Pang X, Mu Y, He H, Shuai S, Wang J, et al. Emission reduction potential of using ethanol–biodiesel–diesel fuel blend on a heavy-duty diesel engine. Atmospheric Environment. 2006;40(14):2567-74.
11
12. Zhu L, Cheung C, Zhang W, Huang Z. Combustion, performance and emission characteristics of a DI diesel engine fueled with ethanol–biodiesel blends. Fuel. 2011;90(5):1743-50.
12
13. Shahir S, Masjuki H, Kalam M, Imran A, Fattah IR, Sanjid A. Feasibility of diesel–biodiesel–ethanol/bioethanol blend as existing CI engine fuel: An assessment of properties, material compatibility, safety and combustion. Renewable and Sustainable Energy Reviews. 2014;32:379-95.
13
14. Koç M, Sekmen Y, Topgül T, Yücesu HS. The effects of ethanol–unleaded gasoline blends on engine performance and exhaust emissions in a spark-ignition engine. Renewable energy. 2009;34(10):2101-6.
14
15. Ometto AR, Hauschild MZ, Roma WNL. Lifecycle assessment of fuel ethanol from sugarcane in Brazil. The international journal of life cycle assessment. 2009;14(3):236-47.
15
ORIGINAL_ARTICLE
The role of folic acid in carcinogenesis, diagnosis, and treatment of cancer
Introduction: Folic acid, also known as folate, is one of the water-soluble B vitamins which its derivatives are involved in many metabolic reactions as cofactor, that are mostly contributed in cell growth. Regarding the role of derived cofactors from this vitamin in reactions such as methylation, production of thymidine and purines; seems that there is a relationship between this vitamin and cancer. Methods: We searched Medline/Pubmed, Scopus, Embase and Web of Science (2000-2017) using term folic acid, carcinogenesis, diagnose and treatment. Our focused was on the articles published within the past 5 years and type of study in culture media, animal models and clinical trials were in our favor. Results: Candidate mechanisms in carcinogenesis for folic acid include 1: changes in DNA and RNA methylation 2: Damage to the integrity and stability of DNA 3: disruption in repair system of DNA. Conclusion: Folic acid in carcinogenesis acts as a double-edged sword. The activity type of folic acid depends on the physiological conditions, dosage of the vitamin, age, individual genotypes, target tissues and stage of the disease in patients. High growth rate of cancer cells leads to increase in cell requests of the vitamin, and on the other hand the cells enhance the number of receptors improving the vitamin absorption. Therefore, increasing number of cell surface receptors, it can be applied for non-invasive diagnosis and target therapy.
https://www.ijbmph.com/article_67209_3c948973ab8261ed51273ee9887a90b4.pdf
2018-05-20
114
121
10.22631/ijbmph.2018.117032.1017
Folic acid
carcinogenesis
Therapeutics
Diagnosis
Jalil
Rashedi
rashedijalil@gmail.com
1
Department of laboratory sciences, Faculty of Para medicine, Tabriz University of medical sciences, Tabriz, Iran
AUTHOR
Maryam
Akbarzadeh
2
Stem Cell and Regenerative Medicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran
AUTHOR
Hosein
Ajami Khiyav
dr_hossein-ajami@yahoo.com
3
Islamic Azad University of Tabriz Faculty of Veterinary Medicine, Tabriz, Iran
AUTHOR
Sanya
Haiaty
sanyahaiaty@gmail.com
4
Department of Clinical Biochemistry and Laboratory Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
AUTHOR
Vahid
Vahedian
5
Rofeydeh Rehabilitation Hospital, University of Social Welfare and Rehabilitation Science (USWR), Tehran, Iran
AUTHOR
Omid
Hasanzadeh
nadia.h6788@yahoo.com
6
Islamic Azad University of Tabriz, Tabriz, Iran
AUTHOR
Nazila
Fathi
n.fathi6788@gmail.com
7
LEAD_AUTHOR
1. Shiralizadeh J, Barmaki H, Haiaty S, Faridvand Y, Mostafazadeh M, Mokarizadeh N, Kamrani A, Isazadeh A, Maroufi NF. The effects of high and low doses of folic acid on oxidation of protein levels during pregnancy: a randomized double-blind clinical trial. Horm Mol Biol Clin Investig. 2017;33(3).doi: https://doi.org/10.1515/hmbci-2017-0039
1
2. Stefanska B, Karlic H, Varga F, abianowska‐Majewska K, Haslberger AG. Epigenetic mechanisms in anti‐cancer actions of bioactive food components–the implications in cancer prevention. Br J Pharmacol. 2012; 167(2):279-97. https://doi.org/10.1111/j.1476-5381.2012.02002.x
2
3. Keijer J, Bekkenkamp-Grovenstein M, Venema D, Dommels YE. Bioactive food components, cancer cell growth limitation and reversal of glycolytic metabolism. Biochim Biophys Acta. 2011; 1807(6):697-706. https://doi.org/10.1016/j.bbabio.2010.08.007
3
4. Maroufi NF, Ghorbanihaghjo A, Melli MS, Vaezi M, Mehrabani Zh, Amirkhiz MB, Rashtchizadeh N. Effects of high and low doses of folic acid on the soluble receptor activator of nuclear factor-kappa b ligand/osteoprotegerin ratio during pregnancy. IJPH. 2017;46(4):517.5. Maddocks OD, Labuschagne CF, Adams PD, Vousden KH. Serine metabolism supports the methionine cycle and DNA/RNA methylation through de novo ATP synthesis in cancer cells. Mol cell. 2016; 61(2):210-21. https://doi.org/10.1016/j.molcel.2015.12.014
4
6. Locasale JW. Serine, glycine and one-carbon units: cancer metabolism in full circle. Nat Rev Cancer. 2013; 13(8):572-83. doi:10.1038/nrc3557
5
7. Strickland KC, Krupenko NI, Krupenko SA. Molecular mechanisms underlying the potentially adverse effects of folate. Clin Chem Lab Med. 2013; 51(3):607-16. https://doi.org/10.1515/cclm-2012-0561
6
8. Bazzano LA, Reynolds K, Holder KN, He J. Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials. Jama. 2006; 296(22):2720-6. doi:10.1001/jama.296.22.2720
7
9. Refsum Helga A. David Smith. Folic Acid for the Prevention of Neural Tube Defects. JAMA pediatrics. 2017; 171 (7): 710-711. doi:10.1001/jamapediatrics.2017.0866
8
10. Kerr J, Anderson C, Lippman SM. Physical activity, sedentary behaviour, diet, and cancer: an update and emerging new evidence. Lancet Oncol. 2017; 1; 18(8):e457-71.
9
https://doi.org/10.1016/S1470-2045(17)30411-4
10
11. Cole BF, Baron JA, Sandler RS, Haile RW, Ahnen DJ, Bresalier RS, et al. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. Jama. 2000; 297(21):2351-9. doi:10.1001/jama.297.21.2351
11
12. Ly A, Lee H, Chen J, Sie KK, Renlund R, Medline A, et al. Effect of maternal and postweaning folic acid supplementation on mammary tumor risk in the offspring. Cancer research. Cancer Res. 2011;71(3):988-97
12
doi: 10.1158/0008-5472.CAN-10-2379
13
13. Ly A, Hoyt L, Crowell J, Kim YI. Folate and DNA methylation. Antioxid Redox Sign. 2012; 17(2):302-26. https://doi.org/10.1089/ars.2012.4554
14
14. Stolzenberg-Solomon RZ, Chang SC, Leitzmann MF, Johnson KA, Johnson C, Buys SS, et al. Folate intake, alcohol use, and postmenopausal breast cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Am J Clin Nutr. 2006; 83(4):895-904. https://doi.org/10.1093/ajcn/83.4.895
15
15. Konno M, Asai A, Kawamoto K, Nishida N, Satoh T, Doki Y, et al. The one-carbon metabolism pathway highlights therapeutic targets for gastrointestinal cancer. Int. J. Oncol. 2017; 1; 50(4):1057-63. https://doi.org/10.3892/ijo.2017.3885
16
16. Yan J, Zierath JR, Barrès R. Evidence for non-CpG methylation in mammals. Exp Cell Res. 2011; 317(18):2555-61. https://doi.org/10.1016/j.yexcr.2011.08.019
17
17. Bjelakovic G, Stojanovic I, Stoimenov TJ, Pavlovic D, Kocic G, Bjelakovic GB, et al. Polyamines, folic acid supplementation and cancerogenesis. Pteridines. 2017; 20; 28(3-4):115-31.
18
https://doi.org/10.1515/pterid-2017-0012
19
18. Collins AR, Azqueta A, Langie SA. Effects of micronutrients on DNA repair. Eur J Nutr. 2012; 51(3):261-79.
20
19. Jacob RA, Gretz DM, Taylor PC, James SJ, Pogribny IP, Miller BJ, et al. Moderate folate depletion increases plasma homocysteine and decreases lymphocyte DNA methylation in postmenopausal women. J Nutr. 1998; 128(7):1204-12. https://doi.org/10.1093/jn/128.7.1204
21
20. Wasson GR, McGlynn AP, McNulty H, et al. Global DNA and p53 region-specific hypomethylation in human colonic cells is induced by folate depletion and reversed by folate supplementation. J Nutr. 2006; 136(11):2748-53. https://doi.org/10.1093/jn/136.11.2748
22
21. Cooper DN, Mort M, Stenson PD, Ball EV, Chuzhanova NA. Methylation-mediated deamination of 5-methylcytosine appears to give rise to mutations causing human inherited disease in CpNpG trinucleotides, as well as in CpG dinucleotides. Hum Genomics. 2010; 4(6):406. https://doi.org/10.1186/1479-7364-4-6-406.
23
22. Lubecka-Pietruszewska K, Kaufman-Szymczyk A, Stefanska B, Fabianowska-Majewska K. Folic acid enforces DNA methylation-mediated transcriptional silencing of PTEN, APC and RARbeta2 tumour suppressor genes in breast cancer. Biochem Biophys Res Commun. 2013; 430(2):623-8. https://doi.org/10.1016/j.bbrc.2012.11.103
24
23. Guo M, Liu X, Zheng X, Huang Y, Chen X. m6A RNA Modification Determines Cell Fate by Regulating mRNA Degradation. Cell Reprogram. 2017; 1; 19(4):225-31. https://doi.org/10.1089/cell.2016.0041
25
24. Motorin Y, Helm M. RNA nucleotide methylation. Wiley Interdisciplinary Reviews: RNA. 2011;2(5):611-31.doi: https://doi.org/10.1002/wrna.79
26
25. Sheng X, Li J, Yang L, Chen Z, Zhao Q, Tan L, Zhou Y, Li J. Promoter hypermethylation influences the suppressive role of maternally expressed 3, a long non-coding RNA, in the development of epithelial ovarian cancer. Oncol Rep. 2014;32(1):277-85. doi: https://doi.org/10.3892/or.2014.3208
27
26. Krokan HE, Slupphaug G, Kavli B. Genomic Uracil—Dangers and Benefits in Processing. InThe Base Excision Repair Pathway: Molecular Mechanisms and Role in Disease Development and Therapeutic Design. 2017; 13-62. https://doi.org/10.1142/9789814719735_0002
28
27. Blount BC, Mack MM, Wehr CM, MacGregor JT, Hiatt RA, Wang G, et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci 1997; 94(7):3290-5. https://doi.org/10.1073/pnas.94.7.3290
29
28. Li hp, leu yw, chang ys. Epigenetic changes in virus-associated human cancers. Cell Res. 2005; 15(4):262-71. doi:10.1038/sj.cr.7290295
30
29. Kawakita D, Lee YC, Gren LH, Buys SS, La Vecchia C, Hashibe M. The impact of folate intake on the risk of head and neck cancer in the prostate, lung, colorectal, and ovarian cancer screening trial (PLCO) cohort. Br J Cancer. 2018; 118(2):299. doi:10.1038/bjc.2017.383
31
30. Furlan D, Trapani D, Berrino E, Debernardi C, Panero M, Libera L, Sahnane N, Riva C, Tibiletti MG, Sessa F, Sapino A. Oxidative DNA damage induces hypomethylation in a compromised base excision repair colorectal tumourigenesis. Br J Cancer. 2017; 116(6):793. doi:10.1038/bjc.2017.9
32
31. Choi S-W, Mason JB. Folate and carcinogenesis: an integrated scheme1–3. J Nutr. 2000; 130(2):129-32. https://doi.org/10.1093/jn/130.2.129
33
32. Langie SA, Cameron KM, Ficz G, Oxley D, Tomaszewski B, Gorniak JP, Maas LM, Godschalk RW, van Schooten FJ, Reik W, von Zglinicki T. The ageing brain: effects on DNA repair and DNA methylation in mice. Genes. 2017; 17; 8(2):75. doi:10.3390/genes8020075
34
33. A Messing J, Heuberger R, A Schisa J. Effect of vitamin D3 on lifespan in Caenorhabditis elegans. Curr Aging Sci. 2013; 6(3):220-4.
35
34. Lee D, Hwang W, Artan M, Jeong DE, Lee SJ. Effects of nutritional components on aging. Aging cell 2015; 14(1):8-16. https://doi.org/10.1111/acel.12277
36
35. Rathor L, Akhoon BA, Pandey S, Srivastava S, Pandey R. Folic acid supplementation at lower doses increases oxidative stress resistance and longevity in Caenorhabditis elegans. AGE. 2015; 37(6):1-15.
37
36. Kim Y-I. Folic acid supplementation and cancer risk: point. Cancer Epidemiol Biomarkers Prev. 2008; 17(9):2220-5.
38
doi: 10.1158/1055-9965.EPI-07-2557
39
37. Joshi R, Adhikari S, Patro BS, Chattopadhyay S, Mukherjee T. Free radical scavenging behavior of folic acid: evidence for possible antioxidant activity. Free Radic Biol Med. 2001; 30(12):1390-9. https://doi.org/10.1016/S0891-5849(01)00543-3
40
38. Kim Y-I. Will mandatory folic acid fortification prevent or promote cancer? Am J Clin Nutr. 2004; 80(5):1123-8. https://doi.org/10.1093/ajcn/80.5.1123
41
39. Kim YI. Folate and colorectal cancer: An evidence‐based critical review. Mol Nutr Food Res. 2007; 51(3):267-92. https://doi.org/10.1002/mnfr.200600191
42
40. Nagothu KK, Rishi AK, Jasze
43